Bromosporine
-
Catalog number2652-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameEthyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate
-
DescriptionBromosporine is a broad spectrum bromodomain inhibitor (IC₅₀s = 0.41 µM, 0.29 µM, 0.122 µM and 0.017 µM for BRD2, BRD4, BRD9 and CECR2, respectively). At 1 µM, Bromosporine accelerates FRAP recovery of BRD4 and CREBBP, while displaying no activities against TIF1α, BAZ2A, and SMARCA2 even at 10 µM.
-
CAS Number1619994-69-2
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₇H₂₀N₆O₄S
-
Molecular Weight404.44
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~35 mg/ml) or EtOH (~ 10 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA bromodomain family inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
SMILESO=C(OCC)NC1=CC(C2=CC=C(C)C(NS(=O)(C)=O)=C2)=NN3C1=NN=C3C
-
InChiInChI=1S/C17H20N6O4S/c1-5-27-17(24)18-15-9-14(21-23-11(3)19-20-16(15)23)12-7-6-10(2)13(8-12)22-28(4,25)26/h6-9,22H,5H2,1-4H3,(H,18,24)
-
InChi KeyUYBRROMMFMPJAN-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameBromosporine
-
Alternative nameBromosporine
-